Skip to main content

ORIGINAL RESEARCH article

Front. Psychiatry
Sec. Anxiety and Stress Disorders
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1430034

Prevalence and Correlates of Post-Stroke Anxiety in Changde, China During 2023 Following the Lifting of COVID-19 Restrictions

Provisionally accepted
Shangyu Luo Shangyu Luo Yunjun Hong Yunjun Hong Jun Wen Jun Wen *Xiaobo Zhang Xiaobo Zhang *
  • The First People's Hospital of Changde City, Changde, China

The final, formatted version of the article will be published soon.

    Background: Studies on post-stroke anxiety (PSA) following the lifting of COVID-19 restriction measures are currently lacking. We investigated the factors affecting PSA after full release of COVID-19 epidemic in China Methods: Patients with stroke admitted to the First People's Hospital of Changde City from March 2023 to September 2023 participated in a questionnaire survey comprising a general demographic questionnaire, the Generalized Anxiety Scale-7.Additionally, data on the National Institutes of Health Stroke Scale, modified Rankin Scale, C-reactive protein (CRP), thyroidstimulating hormone (TSH), homocysteine, TOAST classification, and the stroke site were collected, and the correlations between these indices and the mental health conditions of the patients were evaluated.Results: Among 947 patients, the incidence of PSA was 14.57%.PSA was not linked to prior COVID-19 infection. This study found that Sleep duration (P=0.01), hyperlipidemia(P=0.01), migraine(P=0.02), and family history of stroke(P=0.01) were associated with PSA.conclusions：Our study found that the prevalence of PSA was 14.57%. In addition, sleep duration, hyperlipidemia, migraine and family history of stroke were independent risk factors for PSA following the lifting of COVID-19 restrictions.

    Keywords: COVID-19, Stroke, Anxiety, Hyperlipidemia, Migraine

    Received: 20 May 2024; Accepted: 20 Sep 2024.

    Copyright: © 2024 Luo, Hong, Wen and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jun Wen, The First People's Hospital of Changde City, Changde, China
    Xiaobo Zhang, The First People's Hospital of Changde City, Changde, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.